Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel

PHASE2CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 29, 2019

Study Completion Date

April 29, 2019

Conditions
Pancreatic Cancer
Interventions
DRUG

Nab-paclitaxel

DRUG

Gemcitabine

Trial Locations (18)

1070

ULB Hôpital Erasme, Brussels

1200

Cliniques Universitaires St Luc, Brussels

2300

AZ Turnhout, Turnhout

2500

Heilig Hartziekenhuis Lier, Lier

2650

UZ Antwerpen, Edegem

2800

AZ Sint Maarten, Mechelen

2930

AZ Klina, Brasschaat

3000

UZ Leuven, Leuven

4000

CHC St Joseph, Liège

CHR Citadelle, Liège

CHU Sart-Tilman, Liège

5000

Clinique St Elisabeth, Namur

6110

CHU de Charleroi, Charleroi

8310

AZ St Lucas, Bruges

9000

AZ Maria Middelares, Ghent

UZ Gent, Ghent

9300

OLV Ziekenhuis Aalst, Aalst

Unknown

AZ Delta, Roeselare

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Universitaire Ziekenhuizen KU Leuven

OTHER